Is NAD+ face cream better than hyaluronic acid?+
Not as a blanket rule. Hyaluronic acid is mainly a hydration-focused cosmetic ingredient, while topical NAD+ is usually positioned as cosmetic skin support with more limited direct human outcome evidence. The better fit depends on goals, skin sensitivity, product quality, routine complexity, and clinician guidance.
Can I use NAD+ face cream and hyaluronic acid together?+
Some routines may combine hydrating products with other topical actives, but patients should avoid layering many products at once if they have burning, peeling, rash, acne flares, rosacea, eczema, recent procedures, or unclear product labels. Ask the clinic or dermatologist how to introduce products safely.
Is hyaluronic acid the same as filler?+
No. Topical hyaluronic acid serums and moisturizers are skin-surface products. Injectable hyaluronic acid fillers are medical procedures with different risks, training requirements, and regulation. A topical product should not be marketed as producing filler-like results.
Is topical NAD+ FDA-approved for anti-aging?+
No. Compounded NAD+ face cream used in wellness or cosmetic settings is not an FDA-approved finished drug for anti-aging, acne, melasma, wound healing, scar repair, skin lightening, or disease treatment. Responsible clinics should keep cosmetic claims conservative.
Who should be careful with NAD+ face cream or hyaluronic acid products?+
Patients should ask about pregnancy or breastfeeding, sensitive skin, eczema, rosacea, allergy history, active rash, open skin, recent laser or peel procedures, acne medications, and other active topicals. Some people need dermatology care before adding any new skincare active.
What online skincare sellers should I avoid?+
Avoid sellers promising age reversal, wrinkle erasure, filler-like effects, scar repair, wound healing, skin lightening, or disease treatment. Also avoid compounded products without medical intake, pharmacy transparency, ingredient details, labeling, adverse-event instructions, and follow-up access.